Wednesday, February 28, 2024
12 - 1 p.m. ET
1.0 CME credit offered at no cost.
KEYNOTE SPEAKER
Lanla F. Conteh, MD, MPH, MBA
The Ohio State University
OBJECTIVES
- Screen and identify patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).
- Describe current disparities in care in MASLD risk, assessment, and management.
- Manage contributing risk factors to MASLD in patient care.
- Counsel patients on current risks, treatment options, and prognosis.
|